Search Results

Displaying Results 1-1 of 1 "'AGLE'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight

Mar 17, 2026, 10:01 ET Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight

pipeline, including D-Fi/FCX-007 (Castle Creek Biosciences), EBESANAR (RHEACELL and AOP Health), Redasemtide (SHIONOGI/StemRIM), KB803 (Krystal Biotech), AGLE-102 (Aegle Therapeutics), AC-203 (TWi Biotechnology), and others in the coming years.LAS VEGAS,

More news about: DelveInsight Business Research, LLP

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.